Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1996 Feb;51(2):150–154. doi: 10.1136/thx.51.2.150

Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element.

R Keul 1, M Roth 1, E Papakonstantinou 1, M Nauck 1, A P Perruchoud 1, L H Block 1
PMCID: PMC473024  PMID: 8711646

Abstract

BACKGROUND: Broncho-Vaxom (OM-85 BV) increases the resistance of the respiratory tract to bacterial infections by modulating host immune responses. The compound increases serum IgG levels but decreases IgE levels in patients suffering from chronic bronchitis or chronic obstructive pulmonary disease. It increases concentrations of gamma-interferon (IFN-gamma), IgA, and interleukin (IL)-2 in bronchoalveolar lavage fluid of patients with bronchitis. Treatment with OM-85 BV increases the number of T helper and natural killer cells. In this study the effects of OM-85 BV on transcription of cytokines is investigated in human lung fibroblasts. METHODS: Transcription and synthesis of IL-6 and IL-8 were assessed in cultured primary human lung fibroblasts using standard methods of Northern blot analysis for the level of mRNAs and enzyme linked immunosorbent assay for proteins. RESULTS: Broncho-Vaxom (OM-85 BV) at different concentrations induced transcription of IL-6 and IL-8. The effect of the drug on transcription of IL-6 and IL-8 genes correlated with secretion of the proteins into cell supernatants. OM-85 BV-dependent expression of the interleukin genes involved C-Fos/serum responsive element (C-Fos/SRE). CONCLUSIONS: The data suggest that the various immunopharmacological activities of OM-85 BV that have been described in clinical studies may be explained by its ability to induce expression of IL-6 and IL-8.

Full text

PDF
150

Images in this article

151Image
on p.151
153Image
on p.153

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aderka D., Le J. M., Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol. 1989 Dec 1;143(11):3517–3523. [PubMed] [Google Scholar]
  2. Baggiolini M., Walz A., Kunkel S. L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest. 1989 Oct;84(4):1045–1049. doi: 10.1172/JCI114265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bessler W. G., Kleine B., Martinez Alonso C., Biesert L., Strecker M., Wiesmüller K. H., Metzger J., Jung G. Biological activity of bacterial surface components: bacterial extracts and defined bacterial cell wall components as immunomodulators. Lung. 1990;168 (Suppl):707–715. doi: 10.1007/BF02718197. [DOI] [PubMed] [Google Scholar]
  4. Denis M. Interleukin-6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J Leukoc Biol. 1992 Aug;52(2):197–201. doi: 10.1002/jlb.52.2.197. [DOI] [PubMed] [Google Scholar]
  5. Derenne J. P., Delclaux B. Clinical experience with OM-85 BV in upper and lower respiratory tract infections. Respiration. 1992;59 (Suppl 3):28–31. doi: 10.1159/000196128. [DOI] [PubMed] [Google Scholar]
  6. DiCosmo B. F., Geba G. P., Picarella D., Elias J. A., Rankin J. A., Stripp B. R., Whitsett J. A., Flavell R. A. Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest. 1994 Nov;94(5):2028–2035. doi: 10.1172/JCI117556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Duchow J., Marchant A., Delville J. P., Schandene L., Goldman M. Upregulation of adhesion molecules induced by broncho-vaxom on phagocytic cells. Int J Immunopharmacol. 1992 Jul;14(5):761–766. doi: 10.1016/0192-0561(92)90073-t. [DOI] [PubMed] [Google Scholar]
  8. Elias J. A., Trinchieri G., Beck J. M., Simon P. L., Sehgal P. B., May L. T., Kern J. A. A synergistic interaction of IL-6 and IL-1 mediates the thymocyte-stimulating activity produced by recombinant IL-1-stimulated fibroblasts. J Immunol. 1989 Jan 15;142(2):509–514. [PubMed] [Google Scholar]
  9. Fontanges R., Bottex C., Cristau B., Burckhart M. F. Influence of a bacterial extract on antigen presentation and protection against experimental infections. Lung. 1990;168 (Suppl):716–719. doi: 10.1007/BF02718198. [DOI] [PubMed] [Google Scholar]
  10. Kasahara K., Strieter R. M., Chensue S. W., Standiford T. J., Kunkel S. L. Mononuclear cell adherence induces neutrophil chemotactic factor/interleukin-8 gene expression. J Leukoc Biol. 1991 Sep;50(3):287–295. doi: 10.1002/jlb.50.3.287. [DOI] [PubMed] [Google Scholar]
  11. Kohase M., May L. T., Tamm I., Vilcek J., Sehgal P. B. A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol. 1987 Jan;7(1):273–280. doi: 10.1128/mcb.7.1.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lewin I., Nechushtan H., Ke Q., Razin E. Regulation of AP-1 expression and activity in antigen-stimulated mast cells: the role played by protein kinase C and the possible involvement of Fos interacting protein. Blood. 1993 Dec 15;82(12):3745–3751. [PubMed] [Google Scholar]
  13. Marchant A., Duchow J., Goldman M. Adhesion molecules in antibacterial defenses: effects of bacterial extracts. Respiration. 1992;59 (Suppl 3):24–27. doi: 10.1159/000196127. [DOI] [PubMed] [Google Scholar]
  14. Matsushima K., Oppenheim J. J. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine. 1989 Nov;1(1):2–13. doi: 10.1016/1043-4666(89)91043-0. [DOI] [PubMed] [Google Scholar]
  15. Mauel J., Van Pham T., Kreis B., Bauer J. Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages. Int J Immunopharmacol. 1989;11(6):637–645. doi: 10.1016/0192-0561(89)90149-5. [DOI] [PubMed] [Google Scholar]
  16. Mauël J. Macrophage activation by OM-85 BV. Respiration. 1992;59 (Suppl 3):14–18. doi: 10.1159/000196125. [DOI] [PubMed] [Google Scholar]
  17. Mauël J., Pham T. V., Kreis B., Corradin-Betz S., Bauer J. Evaluation of assay procedures measuring macrophage stimulation by immunomodulators in vitro. Dev Biol Stand. 1992;77:71–77. [PubMed] [Google Scholar]
  18. Mauël J. Stimulation of immunoprotective mechanisms by OM-85 BV. A review of results from in vivo and in vitro studies. Respiration. 1994;61 (Suppl 1):8–15. doi: 10.1159/000196372. [DOI] [PubMed] [Google Scholar]
  19. Moniuszko T., Rogalewska A., Chyrek-Borowska S. The effect of therapy with selected immunomodulators on interleukin-2 production by peripheral blood lymphocytes. Pneumonol Alergol Pol. 1992;60 (Suppl 2):120–121. [PubMed] [Google Scholar]
  20. Nakamura H., Yoshimura K., Jaffe H. A., Crystal R. G. Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem. 1991 Oct 15;266(29):19611–19617. [PubMed] [Google Scholar]
  21. Okada S., Suda T., Suda J., Tokuyama N., Nagayoshi K., Miura Y., Nakauchi H. Effects of interleukin 3, interleukin 6, and granulocyte colony-stimulating factor on sorted murine splenic progenitor cells. Exp Hematol. 1991 Jan;19(1):42–46. [PubMed] [Google Scholar]
  22. Palma-Carlos A. G., Palma-Carlos M. L. Effect of oral bacterial lysates on serum immunoglobulins. Allerg Immunol (Paris) 1989 Nov;21(9):354–356. [PubMed] [Google Scholar]
  23. Paupe J. Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections. Respiration. 1991;58(3-4):150–154. doi: 10.1159/000195916. [DOI] [PubMed] [Google Scholar]
  24. Riedy M. C., Stewart C. C. Inhibitory role of interleukin-6 in macrophage proliferation. J Leukoc Biol. 1992 Jul;52(1):125–127. doi: 10.1002/jlb.52.1.125. [DOI] [PubMed] [Google Scholar]
  25. Roth M., Emmons L. R., Perruchoud A., Block L. H. Expressions of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase genes are stimulated by recombinant platelet-derived growth factor isomers. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1888–1892. doi: 10.1073/pnas.88.5.1888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Roth M., Solèr M., Hornung M., Emmons L. R., Stulz P., Perruchoud A. P. Cell cultures from cryopreserved human lung tissue. Tissue Cell. 1992;24(4):455–459. doi: 10.1016/0040-8166(92)90061-b. [DOI] [PubMed] [Google Scholar]
  27. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S. C., Dinarello C. A. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990 Jan 1;75(1):40–47. [PubMed] [Google Scholar]
  28. Schröder J. M. The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J Exp Med. 1989 Sep 1;170(3):847–863. doi: 10.1084/jem.170.3.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sheppard M. N., Harrison N. K. New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis. Thorax. 1992 Dec;47(12):1064–1074. doi: 10.1136/thx.47.12.1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Srinivas S., Sironmani T. A., Shanmugam G. Dimethyl sulfoxide inhibits the expression of early growth-response genes and arrests fibroblasts at quiescence. Exp Cell Res. 1991 Oct;196(2):279–286. doi: 10.1016/0014-4827(91)90262-s. [DOI] [PubMed] [Google Scholar]
  31. Strieter R. M., Koch A. E., Antony V. B., Fick R. B., Jr, Standiford T. J., Kunkel S. L. The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. J Lab Clin Med. 1994 Feb;123(2):183–197. [PubMed] [Google Scholar]
  32. Ulich T. R., Yin S., Guo K., Yi E. S., Remick D., del Castillo J. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol. 1991 May;138(5):1097–1101. [PMC free article] [PubMed] [Google Scholar]
  33. Uyttenhove C., Coulie P. G., Van Snick J. T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. J Exp Med. 1988 Apr 1;167(4):1417–1427. doi: 10.1084/jem.167.4.1417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vercelli D., Jabara H. H., Arai K., Yokota T., Geha R. S. Endogenous interleukin 6 plays an obligatory role in interleukin 4-dependent human IgE synthesis. Eur J Immunol. 1989 Aug;19(8):1419–1424. doi: 10.1002/eji.1830190811. [DOI] [PubMed] [Google Scholar]
  35. Walther Z., May L. T., Sehgal P. B. Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines. J Immunol. 1988 Feb 1;140(3):974–977. [PubMed] [Google Scholar]
  36. Wybran J., Libin M., Schandene L. Activation of natural killer cells and cytokine production in humans by bacterial extracts (OM-85 BV). Lung. 1990;168 (Suppl):720–725. doi: 10.1007/BF02718199. [DOI] [PubMed] [Google Scholar]
  37. Ziesche R., Roth M., Papakonstantinou E., Nauck M., Hörl W. H., Kashgarian M., Block L. H. A granulocyte inhibitory protein overexpressed in chronic renal disease regulates expression of interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):301–305. doi: 10.1073/pnas.91.1.301. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES